
EU’s CHMP Recommends Approving Perioperative Nivolumab Combo in NSCLC
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of neoadjuvant nivolumab (Opdivo) plus chemotherapy in combination with adjuvant nivolumab after surgery for patients with PD-L1– …